Curr Top Microbiol Immunol. 2008;317:125-53.

The molecular basis of antibody protection against West Nile virus.

Source

Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, Box 8051, St. Louis, MO 63110, USA.

Abstract

West Nile virus (WNV) infection of mosquitoes, birds, and vertebrates continues to spread in the Western Hemisphere. In humans, WNV infects the central nervous system and causes severe disease, primarily in the immunocompromised and elderly. In this review we discuss the mechanisms by which antibody controls WNV infection. Recent virologic, immunologic, and structural experiments have enhanced our understanding on how antibodies neutralize WNV and protect against disease. These advances have significant implications for the development of novel antibody-based therapies and targeted vaccines.

PMID:: 17990792; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Medical

West Nile Virus - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. [Viral Immunol. 2003]
Review Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus.
Diamond MS, Shrestha B, Mehlhop E, Sitati E, Engle M. Viral Immunol. 2003; 16(3):259-78.
Review The molecular basis of antibody-mediated neutralization of West Nile virus. [Expert Opin Biol Ther. 2007]
Review The molecular basis of antibody-mediated neutralization of West Nile virus.
Oliphant T, Diamond MS. Expert Opin Biol Ther. 2007 Jun; 7(6):885-92.
Review The structural immunology of antibody protection against West Nile virus. [Immunol Rev. 2008]
Review The structural immunology of antibody protection against West Nile virus.
Diamond MS, Pierson TC, Fremont DH. Immunol Rev. 2008 Oct; 225:212-25.
Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus. [Vaccine. 2008]
Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus.
Martina BE, Koraka P, van den Doel P, van Amerongen G, Rimmelzwaan GF, Osterhaus AD. Vaccine. 2008 Jan 10; 26(2):153-7. Epub 2007 Nov 20.
A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice. [Virol J. 2010]
A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.
Spohn G, Jennings GT, Martina BE, Keller I, Beck M, Pumpens P, Osterhaus AD, Bachmann MF. Virol J. 2010 Jul 6; 7:146. Epub 2010 Jul 6.

See reviews... See all...

Cited by 1 PubMed Central article

Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge. [Immunology. 2010]
Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge.
Gershoni-Yahalom O, Landes S, Kleiman-Shoval S, Ben-Nathan D, Kam M, Lachmi BE, Khinich Y, Simanov M, Samina I, Eitan A, et al. Immunology. 2010 Aug; 130(4):527-35. Epub 2010 Mar 16.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The molecular basis of antibody protection against West Nile virus.
The molecular basis of antibody protection against West Nile virus.
Curr Top Microbiol Immunol. 2008 ;317:125-53.

PubMed
[Dose-dependence of bone morphogenetic protein 2-derived peptide on osteogenic i...
[Dose-dependence of bone morphogenetic protein 2-derived peptide on osteogenic induction in marrow mesenchymal stem cells in vitro].
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2007 Oct ;21(10):1118-22.

PubMed
Comparative pathway annotation with protein-DNA interaction and operon informati...
Comparative pathway annotation with protein-DNA interaction and operon information via graph tree decomposition.
Pac Symp Biocomput. 2007 :496-507.

PubMed
Ab initio prediction of transcription factor binding sites.
Ab initio prediction of transcription factor binding sites.
Pac Symp Biocomput. 2007 :484-95.

PubMed
Prevalence of down syndrome among children and adolescents in metropolitan Atlan...
Prevalence of down syndrome among children and adolescents in metropolitan Atlanta.
Birth Defects Res A Clin Mol Teratol. 2007 Nov ;79(11):765-74.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

The molecular basis of antibody protection against West Nile virus.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information